×
Key figures 2023 · Financial calendar · Financial publications · Annual General Meeting 2023 · Annual Press and Analyst Conference · Company Presentations.
The Investor Relations website contains information about Aerovate Therapeutics, Inc.'s business for stockholders, potential investors, and financial ...
We were founded in 1996 by a family seeking a cure for their daughter's pulmonary arterial hypertension, or PAH. Today, we have six FDA-approved therapies that ...
People also ask
The company operates through its two wholly owned subsidiaries, Liquidia Technologies, Inc. and Liquidia PAH, LLC. Liquidia Technologies has developed YUTREPIA™ ...
Aktie · Kennzahlen 2023 · Finanzkalender · Finanzpublikationen · Hauptversammlung 2023 · Bilanzpresse- und Analystenkonferenz · Unternehmenspräsentationen.
The Investor Relations website contains information about Gossamer Bio's business for stockholders, potential investors, and financial analysts.
Events & Presentations · Stock Information · Analyst ... Investor FAQs IR Contact Email Alerts Proxy Online ... pulmonary arterial hypertension (PAH). Liquidia ...
The Investor Relations website contains information about Pulmonx Corporation's business for stockholders, potential investors, and financial analysts.
Mar 25, 2024 · Developed specifically for pulmonary arterial hypertension (PAH) ... investor relations section of the Company ... Investor Contact ir@aerovatetx ...
Mar 22, 2024 · ... Pulmonary Arterial Hypertension (PAH) ... (PAH, World Health Organization [WHO] Group I) and WHO ... Investor-relations@its.jnj.com. SOURCE ...